Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
150 participants
OBSERVATIONAL
2022-09-29
2024-06-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
COVID-19 Pregnancy Related Immunological, Clinical and Epidemiological Factors and Perinatal Outcomes
NCT04659759
Multisite Observational Maternal and Infant Study for COVID-19
NCT05031468
Pregnant Women Vaccinated Against Covid-19.
NCT04957953
Vaccination Against COVID-19 in Pregnant and Lactating Women in Belgium
NCT05618548
In Utero Exposure to SARS-CoV-2 (COVID-19) and Cardiovascular and Metabolic Endpoints in Early Life
NCT04921241
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
COVID-19 booster in pregnancy
Pregnant singletons who have received COVID-19 booster in pregnancy
Bivalent COVID-19 Booster
Bivalent COVID-19 Booster by Pfizer or Moderna
COVID-19 booster in breastfeeding
Breastfeeding individuals who have received COVID-19 booster while breastfeeding
Bivalent COVID-19 Booster
Bivalent COVID-19 Booster by Pfizer or Moderna
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bivalent COVID-19 Booster
Bivalent COVID-19 Booster by Pfizer or Moderna
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Received mRNA bivalent COVID-19 booster during 1) pregnancy or 2) breastfeeding
Exclusion Criteria
* Unable to provide consent
13 Years
55 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Walter Reed Army Institute of Research (WRAIR)
FED
Nemours Childrens Health
UNKNOWN
Thomas Jefferson University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rupsa C. Boelig
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rupsa C Boelig, MD
Role: PRINCIPAL_INVESTIGATOR
Thomas Jefferson University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
22F.452
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.